Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020160
Filing Date
2025-07-22
Accepted
2025-07-22 21:45:05
Documents
1
Period of Report
2025-07-20

Document Format Files

Seq Description Document Type Size
1 form4-07222025_090701.html 4  
1 form4-07222025_090701.xml 4 7543
  Complete submission text file 0001415889-25-020160.txt   9022
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 13011 MCCALLEN PASS BUILDING A, SUITE 100 AUSTIN TX 78753
Business Address
Brophy Michael Burkes (Reporting) CIK: 0001697362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37478 | Film No.: 251141502